G. Laïssa Ouedraogo

Statistics

Publications

Citations

209

H-Index

Active since

2010

Affiliations

National Institutes of Health(Current)

National Institute of Allergy and Infectious Diseases

Science Applications International Corporation (United States)

Henry M. Jackson Foundation

Walter Reed Army Institute of Research

G. Laïssa Ouedraogo is an author at National Institutes of Health specializing in infectious diseases, public health, and viral vector immunogenicity.

Publications per year

2010–2019

Publications

Transmitted Raltegravir Resistance in An HIV-1 Crf_Ag-Infected Patient

Sarita D. Boyd, Frank Maldarelli, Irini Sereti et al. · Antiviral Therapy · 2011 · 70 citations

Life Sciences, Infectious Diseases, Pharmacotherapy +17

Safety and immunogenicity of a multivalent HIV vaccine comprising envelope protein with either DNA or NYVAC vectors (HVTN 096): a phase 1b, double-blind, placebo-controlled trial

Giuseppe Pantaleo, Holly Janes, Shelly Karuna et al. · The Lancet HIV · 2019 · 50 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

d-Dimer and CRP levels are elevated prior to antiretroviral treatment in patients who develop IRIS

Brian Porter, G. Laïssa Ouedraogo, Jessica N. Hodge et al. · Clinical Immunology · 2010 · 48 citations

Public Health, Clinical Pharmacy, Hiv Control +5

Safety and Immunogenicity of PENNVAX-G DNA Prime Administered by Biojector 2000 or CELLECTRA Electroporation Device With Modified Vaccinia Ankara-CMDR Boost

Julie A. Ake, Alexandra Schuetz, Poonam Pegu et al. · The Journal of Infectious Diseases · 2017 · 28 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Status of HIV Case-Based Surveillance Implementation — 39 U.S. PEPFAR-Supported Countries, May–July 2019

Joshua R. Holmes, Thu–Ha Dinh, Nasim Farach et al. · MMWR Morbidity and Mortality Weekly Report · 2019 · 13 citations · Full text

Public Health, Infectious Diseases, Public Health Practice +17

1–5 of 5